At Shire, the patient is at the center of everything we do. From our programs and services that directly address specific patient needs, to our patient advocates working collaboratively and tirelessly with organizations around the globe to improve lives – we feel a responsibility to sustain and develop the kinds of programs and resources that benefit our patients most.
To report suspected side effects please email: DrugSafety@Shire.com or contact:
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
BUCCOLAM 2.5 mg, 5 mg, 7.5 mg and 10 mg Oromucosal Solution Alert
Please click here for information and guidance for patients and carers regarding the Buccolam tip-cap issue and correct use of the product.
Our Patient Advocacy Team builds and sustains mutually beneficial relationships with patient advocacy organizations.
We consider it a core responsibility to broaden understanding and awareness of the conditions our medicines help treat.